Valuation: Ainos, Inc.

Market Cap 1.03Cr 90.64L 84.37L 77.49L 1.45Cr 99Cr 1.47Cr 10Cr 3.92Cr 49Cr 3.87Cr 3.79Cr 168.75Cr P/E 2024
-0.29x
P/E 2025 -0.47x
Enterprise Value 2.09Cr 1.84Cr 1.71Cr 1.57Cr 2.95Cr 200.36Cr 2.99Cr 20Cr 7.94Cr 99Cr 7.84Cr 7.67Cr 341.95Cr EV / Sales 2024
701x
EV / Sales 2025 162x
Free-Float
33.62%
Yield 2024 *
-
Yield 2025 -
1 day-5.00%
1 week-19.39%
Current month-31.44%
1 month-23.12%
3 months-24.86%
6 months-22.97%
Current year-18.90%
1 week 1.32
Extreme 1.32
1.67
1 month 1.32
Extreme 1.32
2.31
Current year 1.26
Extreme 1.26
3.88
1 year 1.26
Extreme 1.26
4.5
3 years 1.26
Extreme 1.26
25.5
5 years 1.26
Extreme 1.26
450
10 years 1.26
Extreme 1.26
1,781.25
Manager TitleAgeSince
Chief Executive Officer 56 15/04/2021
Director of Finance/CFO 54 15/03/2024
Director TitleAgeSince
Director/Board Member 49 15/04/2021
Director/Board Member 54 15/04/2021
Director/Board Member 42 15/04/2021
Date Insider Type Main position Quantity % Market Cap.
05/06/26 Buy

Director

3,500 0.0501%
03/06/26 Buy

Director

2,000 0.0286%
28/05/26 Buy

Director

250 0.0036%
Change 5-day change 1-year change 3-year change Capi.($)
-5.00%-19.39%-48.45%-94.68% 1.03Cr
-1.54%+5.08%+16.98%-2.59% 21TCr
+2.61%-3.60%-4.37%-25.81% 13TCr
+5.73%+3.30%-28.04%+8.34% 12TCr
+2.85%+3.36%-57.12%-13.15% 6.58TCr
+0.50%-3.14%+3.80%-9.37% 4.76TCr
+1.43%+1.25%-25.87%-31.67% 4.44TCr
-0.49%+4.89%+14.74%+7.33% 3.91TCr
-0.93%+0.60%+22.53%+28.04% 3.68TCr
-2.38%+1.51%+73.35%-0.90% 2.94TCr
Average +0.35%-0.91%-3.25%-13.45% 7.28TCr
Weighted average by Cap. +1.32%+0.78%-2.08%-6.12%

Financials

2024 2025
Net sales 20.73T 18.22T 16.96T 15.58T 29.25T 19.88L 29.64T 2L 78.75T 10L 77.81T 76.14T 33.93L 1L 1L 1L 93.31T 2L 1.19Cr 2L 12.08L 5L 58.79L 5L 5L 2.03Cr
Net income -1.49Cr -1.31Cr -1.22Cr -1.12Cr -2.1Cr -142.54Cr -2.13Cr -14Cr -5.65Cr -70Cr -5.58Cr -5.46Cr -243.26Cr -1.48Cr -1.3Cr -1.21Cr -1.11Cr -2.08Cr -141.65Cr -2.11Cr -14Cr -5.61Cr -70Cr -5.54Cr -5.43Cr -241.76Cr
Net Debt 81.07L 71.27L 66.34L 60.93L 1.14Cr 78Cr 1.16Cr 7.89Cr 3.08Cr 38Cr 3.04Cr 2.98Cr 132.69Cr 1.06Cr 93.03L 86.6L 79.53L 1.49Cr 101.49Cr 1.51Cr 10Cr 4.02Cr 50Cr 3.97Cr 3.89Cr 173.21Cr
Logo Ainos, Inc.
Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogren’s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.
Employees
41
Date Price Change Volume
28/26/28 $1.330 -5.00% 58,735
24/26/24 $1.400 -7.28% 39,461
23/26/23 $1.510 -1.95% 14,673
22/26/22 $1.540 -1.28% 19,450
21/26/21 $1.560 -1.89% 36,572
  1. Stock Market
  2. Stocks
  3. AIMD Stock